The English SARS-CoV-2 epidemic has been affected by the emergence of new viral variants such as B.1.177, Alpha and Delta, and changing restrictions. We used statistical models and the agent-based model Covasim, in June 2021, to estimate B.1.177 to be 20% more transmissible than the wild type, Alpha to be 50-80% more transmissible than B.1.177 and Delta to be 65-90% more transmissible than Alpha. Using these estimates in Covasim (calibrated 1 September 2020 to 20 June 2021), in June 2021, we found that due to the high transmissibility of Delta, resurgence in infections driven by the Delta variant would not be prevented, but would be strongly reduced by delaying the relaxation of restrictions by one month and with continued vaccination. This...
Recent months have demonstrated that emerging variants may set back the global COVID-19 response. Th...
The development and deployment of several SARS-CoV-2 vaccines in a little over a year is an unpreced...
Background: SARS-CoV-2 variants of concern, such as Omicron (B.1.1.529), continue to emerge. Assessi...
The English SARS-CoV-2 epidemic has been affected by the emergence of new viral variants such as B.1...
J.P.G.’s work was supported by funding from the UK Health Security Agency and the UK Department of H...
The SARS-CoV-2 epidemic has been extended by the evolution of more transmissible viral variants. In ...
A severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant, VOC 202012/01 (lineage B.1.1...
Background: England's COVID-19 roadmap out of lockdown policy set out the timeline and conditions fo...
In this paper, we estimate the path of daily SARS-CoV-2 infections in England from the beginning of ...
The number of new daily SARS-CoV-2 infections is frantically rising in almost every country of the E...
The SARS-CoV-2 Delta variant, known as B.1.617.2 and first identified in India, is becoming a domina...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were rising during early sum...
Background: Since the emergence of SARS-CoV-2, evolutionary pressure has driven large increases in t...
The introduction of COVID-19 vaccination passes (VPs) by many countries coincided with the Delta var...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were rising during early sum...
Recent months have demonstrated that emerging variants may set back the global COVID-19 response. Th...
The development and deployment of several SARS-CoV-2 vaccines in a little over a year is an unpreced...
Background: SARS-CoV-2 variants of concern, such as Omicron (B.1.1.529), continue to emerge. Assessi...
The English SARS-CoV-2 epidemic has been affected by the emergence of new viral variants such as B.1...
J.P.G.’s work was supported by funding from the UK Health Security Agency and the UK Department of H...
The SARS-CoV-2 epidemic has been extended by the evolution of more transmissible viral variants. In ...
A severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant, VOC 202012/01 (lineage B.1.1...
Background: England's COVID-19 roadmap out of lockdown policy set out the timeline and conditions fo...
In this paper, we estimate the path of daily SARS-CoV-2 infections in England from the beginning of ...
The number of new daily SARS-CoV-2 infections is frantically rising in almost every country of the E...
The SARS-CoV-2 Delta variant, known as B.1.617.2 and first identified in India, is becoming a domina...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were rising during early sum...
Background: Since the emergence of SARS-CoV-2, evolutionary pressure has driven large increases in t...
The introduction of COVID-19 vaccination passes (VPs) by many countries coincided with the Delta var...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were rising during early sum...
Recent months have demonstrated that emerging variants may set back the global COVID-19 response. Th...
The development and deployment of several SARS-CoV-2 vaccines in a little over a year is an unpreced...
Background: SARS-CoV-2 variants of concern, such as Omicron (B.1.1.529), continue to emerge. Assessi...